The ERBB receptor tyrosine kinase family consists of four receptors: epidermal growth factor receptor (EGFR), human EGFR 2 (HER2), HER3, and HER4, which activate oncogenic pathways by homo- or heterodimerization in many types of cancers. The gene discussed is EGFR; the disease is cancer.